83 related articles for article (PubMed ID: 28391890)
1. The association of the blood lead level and serum lipid concentrations may be modified by the genetic combination of the metallothionein 2A polymorphisms rs10636 GC and rs28366003 AA.
Yang CC; Chuang CS; Lin CI; Wang CL; Huang YC; Chuang HY
J Clin Lipidol; 2017; 11(1):234-241. PubMed ID: 28391890
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.
Liu D; Wang M; Tian T; Wang XJ; Kang HF; Jin TB; Zhang SQ; Guan HT; Yang PT; Liu K; Liu XH; Xu P; Zheng Y; Dai ZJ
Aging (Albany NY); 2017 Feb; 9(2):547-555. PubMed ID: 28228606
[TBL] [Abstract][Full Text] [Related]
3. Association of metallothionein 2A rs10636 with low mean corpuscular volume (MCV), low mean corpuscular haemoglobin (MCH) in healthy Taiwanese.
Chen RF; Chen PM; Pan CS; Huang CC; Chiang EI
Sci Rep; 2023 Jan; 13(1):1292. PubMed ID: 36690679
[TBL] [Abstract][Full Text] [Related]
4. Effects of Vitamin D Receptor, Metallothionein 1A, and 2A Gene Polymorphisms on Toxicity of the Peripheral Nervous System in Chronically Lead-Exposed Workers.
Liu HL; Chuang HY; Hsu CN; Lee SS; Yang CC; Liu KT
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32340109
[TBL] [Abstract][Full Text] [Related]
5. The association of blood lead levels and renal effects may be modified by genetic combinations of Metallothionein 1A 2A polymorphisms.
Yang CC; Lin CI; Lee SS; Wang CL; Dai CY; Chuang HY
Sci Rep; 2020 Jun; 10(1):9603. PubMed ID: 32541800
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
García M; Álvarez L; Fernández Á; González-Iglesias H; Escribano J; Fernández-Vega B; Villota E; Fernández-Vega Cueto L; Fernández-Vega Á; Coca-Prados M
Ophthalmic Genet; 2017; 38(5):451-458. PubMed ID: 28635422
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.
Krześlak A; Forma E; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
Clin Exp Med; 2014 Feb; 14(1):107-13. PubMed ID: 23053628
[TBL] [Abstract][Full Text] [Related]
8. The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues.
Starska K; Bryś M; Forma E; Olszewski J; Pietkiewicz P; Lewy-Trenda I; Danilewicz M; Krześlak A
Toxicol Appl Pharmacol; 2015 Jun; 285(3):187-97. PubMed ID: 25900616
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans.
Sekovanić A; Jurasović J; Piasek M
Arh Hig Rada Toksikol; 2020 Mar; 71(1):27-47. PubMed ID: 32597135
[TBL] [Abstract][Full Text] [Related]
10. Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population.
Forma E; Krzeslak A; Wilkosz J; Jozwiak P; Szymczyk A; Rozanski W; Brys M
Cancer Genet; 2012 Sep; 205(9):432-5. PubMed ID: 22824183
[TBL] [Abstract][Full Text] [Related]
11. Importance of Genetic Polymorphisms in
Ściskalska M; Ołdakowska M; Milnerowicz H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072023
[TBL] [Abstract][Full Text] [Related]
12. The potential effect of metallothionein 2A -5A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels.
Kayaaltı Z; Aliyev V; Söylemezoğlu T
Toxicol Appl Pharmacol; 2011 Oct; 256(1):1-7. PubMed ID: 21767559
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in metallothionein 1A (MT1A) is associated with cadmium-related excretion of urinary beta 2-microglobulin.
Lei L; Chang X; Rentschler G; Tian L; Zhu G; Chen X; Jin T; Broberg K
Toxicol Appl Pharmacol; 2012 Dec; 265(3):373-9. PubMed ID: 22995156
[TBL] [Abstract][Full Text] [Related]
14. Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.
Krześlak A; Forma E; Chwatko G; Jóźwiak P; Szymczyk A; Wilkosz J; Różański W; Bryś M
Toxicol Appl Pharmacol; 2013 May; 268(3):278-85. PubMed ID: 23466427
[TBL] [Abstract][Full Text] [Related]
15. The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?
Tekin D; Kayaaltı Z; Söylemezoğlu T
Int Arch Occup Environ Health; 2012 Aug; 85(6):631-7. PubMed ID: 22005883
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and polymorphisms in metallothionein 1A and 2A in a Chinese population exposed to cadmium.
Chen X; Lei L; Tian L; Zhu G; Jin T
Sci Total Environ; 2012 Apr; 423():12-7. PubMed ID: 22391096
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc.
Adams SV; Barrick B; Christopher EP; Shafer MM; Makar KW; Song X; Lampe JW; Vilchis H; Ulery A; Newcomb PA
Toxicol Appl Pharmacol; 2015 Dec; 289(3):381-8. PubMed ID: 26529669
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.
Starska K; Krześlak A; Forma E; Olszewski J; Lewy-Trenda I; Osuch-Wójcikiewicz E; Bryś M
Med Oncol; 2014 Jul; 31(7):75. PubMed ID: 24952512
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the association of polymorphisms in the metallothionein 2A gene with cancer risk.
Wang J; Huang P; Zhao W; Ren W; Ai L; Wu L
J Int Med Res; 2020 Aug; 48(8):300060520947937. PubMed ID: 32809904
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein 2A gene polymorphism and trace elements in mother-newborn pairs in the Croatian population.
Sekovanić A; Jurasović J; Piasek M; Pašalić D; Orct T; Grgec AS; Stasenko S; Čakanić KB; Jazbec A
J Trace Elem Med Biol; 2018 Jan; 45():163-170. PubMed ID: 29173474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
